Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1426, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tiotropium bromide improves outcomes, QOL at acceptable cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
Access to resources
Recommend
Tiotropium bromide reduces cost burden, improves QOL in COPD
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :
Tiotropium bromide lessens cost burden, improves QOL in COPD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Deferasirox improves outcomes at acceptable cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. :